Q3 2020 Theravance Biopharma Inc Earnings Call Transcript
Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma Conference Call. (Operator Instructions) Today's conference call is being recorded. And now I would like to turn the call over to Gail Cohen, Vice President, Corporate Communications and Investor Relations. Thank you. Please go ahead.
Good day, good afternoon, and thank you for joining the Theravance Biopharma quarterly conference call to discuss our business. As always, I remind you that this call will contain forward-looking statements, which involve risks and uncertainties, including statements about our development pipeline, expected benefits of our products, the anticipated timing of clinical trials, regulatory filings and expected financial results.
Information concerning factors that could cause results to differ materially from our forward-looking statements is described further in our filings with the SEC.
Now I would direct your attention to Slide 3.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |